HOOKIPA Pharma Inc - FORM 8 (OPD)

Key Information - The disclosure is made by HOOKIPA Pharma Inc. as the offeror in relation to its own securities [1] - The position held as of January 7, 2025, indicates no interests or short positions in HOOKIPA common stock [3][4] - The disclosure includes details of interests held by directors of HOOKIPA Pharma Inc., with minimal shareholding percentages [6][7] Positions of the Party to the Offer - HOOKIPA Pharma Inc. has reported zero interests and short positions in its common stock [3] - No cash-settled or stock-settled derivatives are held by the company [3] Rights to Subscribe for New Securities - There are no rights to subscribe for new securities reported [5] Positions of Persons Acting in Concert - Directors of HOOKIPA Pharma Inc. hold minimal shares, with Julie O'Neill holding 496 shares and David R. Kaufman holding 457 shares, both representing 0.00% of total shareholding [6] - Various stock options and awards are detailed for directors, with vesting dates and exercise prices specified [7][8] Other Information - There are no indemnity or option arrangements reported that may influence dealings in relevant securities [13] - No agreements or understandings regarding voting rights or future acquisitions/disposals of relevant securities are disclosed [14] - No supplemental forms are attached to the disclosure [15]